Access cutting-edge rare unresectable or metastatic braf v600e mutation-positive solid tumors treatment through this clinical trial at a research site in El Paso. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this El Paso location
Preparing your pre-screening questions…
Access rare unresectable or metastatic braf v600e mutation-positive solid tumors specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rare unresectable or metastatic braf v600e mutation-positive solid tumors treatment provided free
Check if you qualify for this rare unresectable or metastatic braf v600e mutation-positive solid tumors clinical trial in El Paso, TX
No-Cost Study Care
Local to El Paso
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a phase IV, pragmatic single-arm prospective, open label study in pediatric (1 years or older) and adult study participants with rare BRAF V600E mutation-positive unresectable or metastatic solid tumors for whom a decision has already been made to be treated with dabrafenib and trametinib, irrespective of the trial participation.
Sponsor: Novartis Pharmaceuticals
Yes, this clinical trial (NCT05868629) has an active research site in El Paso, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for rare unresectable or metastatic braf v600e mutation-positive solid tumors treatment options in El Paso, TX, this clinical trial (NCT05868629) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our El Paso research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rare unresectable or metastatic braf v600e mutation-positive solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all rare unresectable or metastatic braf v600e mutation-positive solid tumors clinical trials near you to find additional studies recruiting in your area.
See all advanced solid tumors clinical trials recruiting in El Paso — not just this study.
Browse Advanced Solid Tumors Trials in El Paso →